Cargando…

Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction

OBJECTIVE: Evidence of therapy for dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) is limited. This study was performed to compare the effects of atorvastatin and rosuvastatin on dysfu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Langping, Hu, Xiangming, Zhang, Haotian, Lu, Haoyu, Lin, Yan, Wang, Weimian, Yu, Bingyan, Liang, Wensheng, Zhou, Yingling, Li, Guang, Dong, Haojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328025/ https://www.ncbi.nlm.nih.gov/pubmed/37377087 http://dx.doi.org/10.1177/03000605231182547

Ejemplares similares

D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction
por: Lin, Yan, et al.
Publicado: (2022)

Triglyceride-glucose index is associated with quantitative flow ratio in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention
por: Yu, Bingyan, et al.
Publicado: (2022)

Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
por: Adel, Esraa M., et al.
Publicado: (2022)

Association between remnant cholesterol, metabolic syndrome, and cardiovascular disease: post hoc analysis of a prospective national cohort study
por: Jin, Junguo, et al.
Publicado: (2023)

Predictive effect of different blood lipid parameters combined with carotid intima-media thickness on coronary artery disease
por: Yu, Bingyan, et al.
Publicado: (2023)

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
por: Hu, Xiangming, et al.
Publicado: (2022)

Effects of atorvastatin and ticagrelor combination therapy on renal function and the levels of suppression of tumorigenicity 2 and interleukin-33 in patients with ST-segment elevation myocardial infarction
por: Zhang, Li, et al.
Publicado: (2020)

Association between the Plasma-Glycosylated Hemoglobin A1c/High-Density Lipoprotein Cholesterol Ratio and Carotid Atherosclerosis: A Retrospective Study
por: Hu, Xiangming, et al.
Publicado: (2021)

Effects of High-Dose Rosuvastatin on Ventricular Remodelling and Cardiac Function in ST-Segment Elevation Myocardial Infarction
por: Luo, Rong, et al.
Publicado: (2020)

Effect of High Dose Rosuvastatin Loading before Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction
por: Kim, Ji Won, et al.
Publicado: (2014)

Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction
por: Yu, You, et al.
Publicado: (2021)

Erratum to: Effect of High Dose Rosuvastatin Loading before Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction
por: Kim, Ji Won, et al.
Publicado: (2014)

Comparison of shock index-based risk indices for predicting in-hospital outcomes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Wang, Guoyu, et al.
Publicado: (2021)

Characteristics and mechanism of reciprocal ST-segment depression in acute ST segment elevation myocardial infarction: Reciprocal ST-segment depression and ST segment elevation myocardial infarction
por: Gao, Qijun, et al.
Publicado: (2022)

Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without
por: Yu, Bingyan, et al.
Publicado: (2023)

Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects
por: Mohamed, Mohamed‐Eslam F., et al.
Publicado: (2021)

Characteristics and long-term mortality of patients with ST-elevation or non-ST-elevation myocardial infarction after orthopaedic surgery
por: Hu, Wenlan, et al.
Publicado: (2021)

Impact of liver cirrhosis on ST-elevation myocardial infarction related shock and interventional management, a nationwide analysis
por: Dar, Sophia Haroon, et al.
Publicado: (2022)

Left ventricular function, strain, and infarct characteristics in patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarctions
por: Demirkiran, Ahmet, et al.
Publicado: (2021)

Clinical characteristics and outcomes of octogenarians presenting with ST elevation myocardial infarction in the Australian population
por: Sim, Wei Liang, et al.
Publicado: (2017)

An embolic ST-segment elevation myocardial infarction
por: Feng, Lv, et al.
Publicado: (2021)

Acute ST-segment elevation myocardial infarction: to be or not to be?
por: Barbur, Maria Carolina Manzur, et al.
Publicado: (2022)

In vivo and In vitro Drug Interactions Study of Glimepride with Atorvastatin and Rosuvastatin
por: Galani, VJ, et al.
Publicado: (2010)

B-Lines by Lung Ultrasound Can Predict Worsening Heart Failure in Acute Myocardial Infarction During Hospitalization and Short-Term Follow-Up
por: He, Jiexin, et al.
Publicado: (2022)

aVR ST‐segment changes and prognosis of ST‐segment elevation myocardial infarction
por: Sedighi, Sogol, et al.
Publicado: (2021)

Effects of atorvastatin loading prior to primary percutaneous coronary intervention on endothelial function and inflammatory factors in patients with ST-segment elevation myocardial infarction
por: YONG, HUIJUAN, et al.
Publicado: (2014)

Severe Hyperthyroidism Presenting with Acute ST Segment Elevation Myocardial Infarction
por: Zhou, Dayan, et al.
Publicado: (2015)

A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol
por: Niedzielski, Mateusz, et al.
Publicado: (2021)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014)

Circulating Sulfatide, A Novel Biomarker for ST-Segment Elevation Myocardial Infarction
por: Li, Gang, et al.
Publicado: (2019)

Effect of Thrombolysis on Circulating Microparticles in Patients with ST-Segment Elevation Myocardial Infarction
por: Li, Zhe, et al.
Publicado: (2023)

False Positive ST-Segment Elevation Myocardial Infarction
por: Jeong, Hae Chang, et al.
Publicado: (2013)

Etiologies and Predictors of ST-Segment Elevation Myocardial Infarction
por: Bae, Myung Hwan, et al.
Publicado: (2013)

Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction
por: Zhang, Enyuan, et al.
Publicado: (2015)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
por: Masadeh, Majed, et al.
Publicado: (2012)

Periodic Rosuvastatin or Atorvastatin Dosing Arrays (PRADA): Patient-Centered Practice
por: Christou, Theodore, et al.
Publicado: (2014)

The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia
por: Vahit, Demir, et al.
Publicado: (2018)

Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence
por: Perez-Calahorra, Sofía, et al.
Publicado: (2019)

Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin
por: Kroonen, Marjolein Y. A. M., et al.
Publicado: (2019)

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Markers in Acute Coronary Syndrome
por: Umrani, Salman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g6c7p6ul4rqnp819gqj68f8ehn